openPR Logo
Press release

Drug Eluting Balloon Market Driven by Growing Adoption in Cardiovascular Interventions, Advanced Drug Delivery Technologies, and Rising Restenosis Management Needs

06-25-2025 08:27 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Drug Eluting Balloon Market

Drug Eluting Balloon Market

The Drug Eluting Balloon Market is expected to grow at a CAGR 10.4% during the forecast period (2024-2031).

The Drug Eluting Balloon Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/drug-eluting-balloon-market?sv

Drug Eluting Balloon Market Landscape Analysis :

The Drug Eluting Balloon Market is gaining traction due to its minimally invasive nature and effectiveness in treating restenosis, particularly in peripheral and coronary artery diseases. Strong clinical outcomes and regulatory approvals are pushing adoption across both emerging and developed healthcare systems.

Drug Eluting Balloon Market: Shifting Industry Trends and Market Potential

Advancements in drug coating technologies and the growing preference for non-stent therapies are key trends reshaping the DEB landscape. With the global rise in cardiovascular and peripheral artery diseases, the market holds significant potential for expansion, especially in Asia-Pacific and Latin America.

Strategic Players Driving the Drug Eluting Balloon Market Forward :

Medtronic, Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Biotronik and Acotec Scientific.

Research Methodology:

The global Drug Eluting Balloon Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/drug-eluting-balloon-market?sv

Segment Covered in the Drug Eluting Balloon Market:

By Product Type - Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon

By Peripheral Drug Eluting Balloon - Paccocath, FreePac, TransPax, EnduraCoat, Others

By End-Users - Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgery Centers, Others

Regional Analysis for Drug Eluting Balloon Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Drug Eluting Balloon Market Research Industry:

➠ Who leads the Drug Eluting Balloon industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Drug Eluting Balloon market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Drug Eluting Balloon market growth?

➠ What are the dominant sales and distribution strategies in the Drug Eluting Balloon industry?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Looking For Full Report? Get it here: https://datamintelligence.com/buy-now-page?report=drug-eluting-balloon-market?sv

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Eluting Balloon Market Driven by Growing Adoption in Cardiovascular Interventions, Advanced Drug Delivery Technologies, and Rising Restenosis Management Needs here

News-ID: 4080902 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Growth Hormone Deficiency Treatment Market Trends and Forecast | Rising Demand from Pediatric & Adult Endocrine Disorders, Driven by Biotech Advances and New Therapies
Growth Hormone Deficiency Treatment Market Trends and Forecast | Rising Demand f …
Growth Hormone Deficiency Treatment Market reached US$ 6.9 billion in 2024 and is expected to reach US$ 9.2 billion by 2032, growing at a CAGR of 12.1% during the forecast period 2025-2032. The Growth Hormone Deficiency Treatment Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions
Neuroprotection Market for Alzheimer's, Parkinson's, and CNS Disorders | Driven by Aging Population, Precision Therapies, and Innovation in Neurodegenerative Drug Development
Neuroprotection Market for Alzheimer's, Parkinson's, and CNS Disorders | Driven …
Neuroprotection Market is expected to grow at a CAGR of 8.2% during the forecast period 2024-2031 The Neuroprotection Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that
Dental Chair Market for Clinics and Mobile Units | Driven by Ergonomic Designs, Digital Integration, and Rising Demand for Smart, Patient-Centered Dental Equipment
Dental Chair Market for Clinics and Mobile Units | Driven by Ergonomic Designs, …
The Dental Chair Market is projected to groe at a CAGR of 5.5 % During the forecast period 2024 - 2031. The Dental Chair Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies,
Overactive Bladder Treatment Market for Urinary Urgency and Incontinence | Driven by Aging Demographics, Minimally Invasive Therapies, and Advances in Urology Care
Overactive Bladder Treatment Market for Urinary Urgency and Incontinence | Drive …
The Overactive Bladder Treatment Market is expected to grow at a CAGR of 3.6% during the forecast period 2024-2031. The Overactive Bladder Treatment Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug